Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Conference Papers

McDonald M; Khoo WH; Mohanty S; Terry R; Chai R; Quinn J; Pettitt J; Xiao Y; Baldock P; Rogers M; Croucher P; Phan T; Ng PY; Pavlos N; Biro M, 2019, 'Intravital imaging of osteoclasts in vivo reveals novel osteoclast fate which may underlie the therapeutic response to Denosumab withdrawal', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY, FL, Orlando, pp. 44 - 45, presented at Annual Meeting of the American-Society-for-Bone-and Mineral Research, FL, Orlando, 20 September 2019 - 23 September 2019,

Rogers MJ; Junankar S; McKenna CE; Sun S; Tri GP, 2014, 'Intravital 2-photon imaging reveals tumour-associated macrophages as the cellular targets underlying the anti-tumour activity of bisphosphonates in vivo.', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, TX, Houston, pp. S14 - S14, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, TX, Houston, 12 September 2014 - 15 September 2014,

Wuerger T; Roschger P; Zwettler E; Fratzl P; Rogers MJ; Klaushofer K; Rumpler M, 2012, 'Osteoclasts on bone and dentin in vitro: Mechanism of degradation and comparison of resorption behaviour', in BONE, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S9 - S9, presented at International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor, AUSTRIA, Vienna, 29 November 2012 - 01 December 2012,

Sun S; Blazewska KM; Kashemirov BA; Roelofs AJ; Coxon FP; Rogers MJ; Ebetino FH; Mckenna MJ; Mckenna CE, 2011, 'Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs', in Phosphorus, Sulfur and Silicon and the Related Elements, pp. 970 - 971,

Shay G; Hornick M; Heys S; Weilbaecher K; Rogers M, 2011, 'Abstract LB-159: Bisphosphonates are internalised by myeloid derived suppressor cells (MDSCs) in vivo in a mouse model of breast cancer', in Cancer Research, American Association for Cancer Research (AACR),

Thompson K; Roelofs AJ; Jauhiainen M; Mönkkönen H; Mönkkönen J; Rogers MJ, 2010, 'Activation of γΔ T cells by bisphosphonates', in Advances in Experimental Medicine and Biology, pp. 11 - 20,

Russell RGG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH, 2007, 'Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy', in Annals of the New York Academy of Sciences, pp. 209 - 257,

Thompson K; Rogers MJ, 2006, 'Alkylamines and bisphosphonates: A common mechanism for activation of γδ T-cells', in Haematologica Reports, pp. 1 - 3

Rogers MJ, 2006, 'New insights into the molecular actions of nitrogen-containing bisphosphonates', in Haematologica Reports, pp. 24 - 25

Lipton A; Berenson JR; Body JJ; Boyce BF; Bruland OS; Carducci MA; Cleeland CS; Clohisy DR; Coleman RE; Cook RJ; Guise TA; Pearse RN; Powles TJ; Rogers MJ; Roodman GD; Smith MR; Suva LJ; Vessella RL; Weilbaecher KN; King L, 2006, 'Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference', in Clinical Cancer Research,

Ebetino FH; Rozé CN; McKenna CE; Barnett BL; Dunford JE; Russell RGG; Mieling GE; Rogers MJ, 2005, 'Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase', in Journal of Organometallic Chemistry, pp. 2679 - 2687,

Shipman CM; Rogers MJ; Vanderkerken K; Van Camp B; Russell RGG; Croucher PI, 2000, 'Bisphosphonates: Mechanisms of action in multiple myeloma', in Acta Oncologica, pp. 829 - 835,

Rogers MJ; Gordon S; Benford HL; Coxon FP; Luckman SP; Monkkonen J; Frith JC, 2000, 'Cellular and molecular mechanisms of action of bisphosphonates', in Cancer, pp. 2961 - 2978,<2961::aid-cncr12>;2-l

Russell RGG; Croucher PI; Rogers MJ, 1999, 'Bisphosphonates: Pharmacology, mechanisms of action and clinical uses', in Osteoporosis International,

Russell RGG; Rogers MJ; Frith JC; Luckman SP; Coxon FP; Benford HL; Croucher PI; Shipman C; Fleisch HA, 1999, 'The pharmacology of bisphosphonates and new insights into their mechanisms of action', in Journal of Bone and Mineral Research, pp. 53 - 65,

Rogers MJ; Watts DJ; Russell RGG, 1997, 'Overview of bisphosphonates', in Cancer, pp. 1652 - 1660,<1652::aid-cncr15>;2-z

Kiernan BW; Fleming J; Rogers MJC; Self TJ; Varela A; Paige AJW; Brown SDM; Steel KP, 1997, 'Analysis of the deaf mouse mutant, whirler', in British Journal of Audiology, pp. 84 - 85

Fleming J; Rogers MJC; Paige A; Varela A; Hughes DC; Ward M; Brown SDM; Steel KP, 1996, 'Progress in the identification of the whirler mutation', in British Journal of Audiology, pp. 139

Back to profile page